Hadley Emily, Yoo Yun Jae, Patel Saaya, Zhou Andrea, Laraway Bryan, Wong Rachel, Preiss Alexander, Chew Rob, Davis Hannah, Brannock M Daniel, Chute Christopher G, Pfaff Emily R, Loomba Johanna, Haendel Melissa, Hill Elaine, Moffitt Richard
RTI International, Durham, NC, USA.
Emory University, Atlanta, GA, USA.
Commun Med (Lond). 2024 Jul 11;4(1):129. doi: 10.1038/s43856-024-00539-2.
Although the COVID-19 pandemic has persisted for over 3 years, reinfections with SARS-CoV-2 are not well understood. We aim to characterize reinfection, understand development of Long COVID after reinfection, and compare severity of reinfection with initial infection.
We use an electronic health record study cohort of over 3 million patients from the National COVID Cohort Collaborative as part of the NIH Researching COVID to Enhance Recovery Initiative. We calculate summary statistics, effect sizes, and Kaplan-Meier curves to better understand COVID-19 reinfections.
Here we validate previous findings of reinfection incidence (6.9%), the occurrence of most reinfections during the Omicron epoch, and evidence of multiple reinfections. We present findings that the proportion of Long COVID diagnoses is higher following initial infection than reinfection for infections in the same epoch. We report lower albumin levels leading up to reinfection and a statistically significant association of severity between initial infection and reinfection (chi-squared value: 25,697, p-value: <0.0001) with a medium effect size (Cramer's V: 0.20, DoF = 3). Individuals who experienced severe initial and first reinfection were older in age and at a higher mortality risk than those who had mild initial infection and reinfection.
In a large patient cohort, we find that the severity of reinfection appears to be associated with the severity of initial infection and that Long COVID diagnoses appear to occur more often following initial infection than reinfection in the same epoch. Future research may build on these findings to better understand COVID-19 reinfections.
尽管新冠疫情已持续三年多,但对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)再感染的情况仍了解不足。我们旨在描述再感染的特征,了解再感染后长期新冠的发展情况,并比较再感染与初次感染的严重程度。
作为美国国立卫生研究院(NIH)“研究新冠以促进康复计划”的一部分,我们使用了来自国家新冠队列协作组的300多万患者的电子健康记录研究队列。我们计算汇总统计量、效应量和 Kaplan-Meier 曲线,以更好地了解新冠再感染情况。
在此,我们验证了先前关于再感染发生率(6.9%)、大多数再感染发生在奥密克戎流行时期以及多次再感染证据的研究结果。我们发现,在同一时期的感染中,初次感染后长期新冠诊断的比例高于再感染。我们报告了再感染前白蛋白水平较低,以及初次感染和再感染之间存在统计学上显著的严重程度关联(卡方值:25,697,p 值:<0.0001),效应量中等(克莱默 V:0.20,自由度 = 3)。经历严重初次感染和首次再感染的个体比初次感染和再感染较轻的个体年龄更大,死亡风险更高。
在一个大型患者队列中,我们发现再感染的严重程度似乎与初次感染的严重程度相关,并且在同一时期,初次感染后长期新冠诊断的发生率似乎比再感染更高。未来的研究可以基于这些发现,以更好地了解新冠再感染情况。